Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which advance care planning method works best for cancer patients?

NCT ID NCT03824158

Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two ways to help people with advanced cancer plan their future medical care: one-on-one talks with a trained nurse or social worker (in person or by phone), or using a website on their own. Over 600 patients took part to see which method helped them think about and discuss their wishes more. The goal is to find the most effective and practical approach for patients and their families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
advance care planning (in-person or web-based)
What this could lead to
If successful, this could show which advance care planning method works best for cancer patients and their families, helping improve end-of-life care.
What could go wrong
This is a completed comparative effectiveness study, not a treatment trial. Results may not apply to all cancer types or settings, and the outcomes focus on planning, not survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

672 people

The number who actually took part.

Started

Aug 2019

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion Criteria: 1. 18 years of age or older 2. Solid tumor 3. The oncologist "would not be surprised" if the patient died within the next year 4. Eastern Cooperative Oncology Group performance status (ECOG PS) of 0, 1, or 2 5. Planning to receive ongoing care at a participating oncology clinic 6. Willing to participate in either a web-based or facilitated program Patient Exclusion Criteria: 1. Does not speak English 2. Inability to consent, using a validated teach-back method 3. Hematologic malignancy 4. No phone for additional study contacts and follow-up interviews 5. Unable to participate in advance care planning, as assessed by clinician 6. Unable to complete the baseline interview Patients will be able to identify and enroll a caregiver, designated by the patient as the primary family member or friend involved in their care and best able to participate in the study. Caregiver Inclusion criteria: 1. 18 years of age or older 2. Family member or friend of an eligible patient 3. Primary person involved in patient's care and best able to participate in the study, as assessed by patient Caregiver Exclusion criteria: 1. Does not speak English 2. No phone for additional study contacts and follow-up interviews 3. Unable to complete the baseline interview

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advance care planning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advance care planning Cancer

Contacts and locations

Locations

  • UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.